You are here

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Westfaelische Wilhelms-Universitaet Muenster, Zentr. f. Derm
Muenster, NRW, 48149 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects with moderate to severe plaque psoriasis on etanercept treatment according to
the Summary of Product Characteristics (SmPC), and applicable local guidelines

- Subjects for whom the decision has already been made to initiate treatment with
etanercept

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Sepsis or risk of sepsis

- Current or recent infections, including chronic or localized, e.g. tuberculosis (TB)
infection

- Vaccination with live vaccine in last 4 weeks, or expected to require such vaccination
during the course of the study

- Pre-existing or recent onset CNS demyelinating disease.

- Class III or IV congestive heart failure as defined by the New York Heart Association
classification or uncompensated congestive heart failure.

- Previous or ongoing treatment with etanercept

- Participation in other clinical or observational studies.

- Patients with psoriatic arthritis requiring continuous etanercept treatment.

NCT00708708
Pfizer
Completed
Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now